Literature DB >> 23340823

Natural killer cells protect mice from DSS-induced colitis by regulating neutrophil function via the NKG2A receptor.

L J Hall1, C T Murphy, A Quinlan, G Hurley, F Shanahan, K Nally, S Melgar.   

Abstract

Natural killer (NK) cells are traditionally considered in the context of tumor surveillance and infection defense but their role in chronic inflammatory disorders such as inflammatory bowel disease is less clear. Here, we investigated the role of NK cells in dextran sodium sulfate (DSS)-induced colitis in mice. Depletion of NK cells impairs the survival of mice with colitis and is linked with dramatic increases in colonic damage, leukocyte infiltration, and pro-inflammatory profiles. Mice depleted of NK cells had increased numbers of neutrophils in colons and mesenteric lymph nodes, compared with control mice, in addition to acquiring a hyper-activation status. In vitro and in vivo studies demonstrate that NK cells downregulate pro-inflammatory functions of activated neutrophils, including reactive oxygen species and cytokine production, by direct cell-to-cell contact involving the NK cell-inhibitory receptor NKG2A. Our results indicate an immunoregulatory mechanism of action of NK cells attenuating DSS-induced colitis neutrophil-mediated inflammation and tissue injury via NKG2A-dependent mechanisms.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23340823     DOI: 10.1038/mi.2012.140

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   7.313


  30 in total

1.  Pellino3 ubiquitinates RIP2 and mediates Nod2-induced signaling and protective effects in colitis.

Authors:  Shuo Yang; Bingwei Wang; Fiachra Humphries; Ruaidhri Jackson; Marc E Healy; Ronan Bergin; Gabriella Aviello; Barry Hall; Deirdre McNamara; Trevor Darby; Aoife Quinlan; Fergus Shanahan; Silvia Melgar; Padraic G Fallon; Paul N Moynagh
Journal:  Nat Immunol       Date:  2013-07-28       Impact factor: 25.606

2.  Impaired NK Cell Activation and Chemotaxis toward Dendritic Cells Exposed to Complement-Opsonized HIV-1.

Authors:  Rada Ellegård; Elisa Crisci; Jonas Andersson; Esaki M Shankar; Sofia Nyström; Jorma Hinkula; Marie Larsson
Journal:  J Immunol       Date:  2015-07-08       Impact factor: 5.422

3.  NK cells regulate CXCR2+ neutrophil recruitment during acute lung injury.

Authors:  Sandra Hoegl; Heidi Ehrentraut; Kelley S Brodsky; Francisco Victorino; Lucy Golden-Mason; Holger K Eltzschig; Eóin N McNamee
Journal:  J Leukoc Biol       Date:  2016-09-06       Impact factor: 4.962

Review 4.  Cross-talk between type 3 innate lymphoid cells and the gut microbiota in inflammatory bowel disease.

Authors:  Kristine-Ann G Buela; Sara Omenetti; Theresa T Pizarro
Journal:  Curr Opin Gastroenterol       Date:  2015-11       Impact factor: 3.287

Review 5.  Intestinal barrier loss as a critical pathogenic link between inflammatory bowel disease and graft-versus-host disease.

Authors:  S C Nalle; J R Turner
Journal:  Mucosal Immunol       Date:  2015-05-06       Impact factor: 7.313

6.  Human NK cells licensed by killer Ig receptor genes have an altered cytokine program that modifies CD4+ T cell function.

Authors:  Lin Lin; Chao Ma; Bo Wei; Najib Aziz; Raja Rajalingam; Susy Yusung; Henry A Erlich; Elizabeth A Trachtenberg; Stephan R Targan; Dermot P B McGovern; James R Heath; Jonathan Braun
Journal:  J Immunol       Date:  2014-06-16       Impact factor: 5.422

Review 7.  Pathogenesis of NEC: Role of the innate and adaptive immune response.

Authors:  Timothy L Denning; Amina M Bhatia; Andrea F Kane; Ravi M Patel; Patricia W Denning
Journal:  Semin Perinatol       Date:  2016-12-09       Impact factor: 3.300

8.  Flagellin-induced expression of CXCL10 mediates direct fungal killing and recruitment of NK cells to the cornea in response to Candida albicans infection.

Authors:  Xiaowei Liu; Nan Gao; Chen Dong; Li Zhou; Qing-Sheng Mi; Theodore J Standiford; Fu-Shin X Yu
Journal:  Eur J Immunol       Date:  2014-08-14       Impact factor: 5.532

Review 9.  The unusual suspects--innate lymphoid cells as novel therapeutic targets in IBD.

Authors:  Rimma Goldberg; Natalie Prescott; Graham M Lord; Thomas T MacDonald; Nick Powell
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-05       Impact factor: 46.802

10.  Combined immunodeficiency with CD4 lymphopenia and sclerosing cholangitis caused by a novel loss-of-function mutation affecting IL21R.

Authors:  Baran Erman; Ivan Bilic; Tatjana Hirschmugl; Elisabeth Salzer; Deniz Çagdas; Saliha Esenboga; Zuhal Akcoren; Ozden Sanal; Ilhan Tezcan; Kaan Boztug
Journal:  Haematologica       Date:  2015-03-13       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.